ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Cells can be programmed into living devices: Here’s how – Medical Design & Outsourcing

Continue reading

2017-08-29 Michael Zand NEWS

Global Cartilage Repair Market 2017-2021 – Gene Therapy and Stem Cell Therapy is the latest Market Trend Making … – Business Wire (press release)

Global Cartilage Repair Market 2017-2021 – Gene Therapy and Stem Cell Therapy is the latest Market Trend Making …Business Wire (press release)The treatment of articular cartilage has evolved tremendously in the past decade. Reparative and restorative… Continue reading

2017-08-29 Michael Zand NEWS

FDA announces action against two stem cell clinics: Is that a ‘crackdown’? – HealthNewsReview.org


Medical Design & Outsourcing

Cells can be programmed into living devices: Here’s how
Medical Design & Outsourcing
The synthetic biological circuits have so far been able to sense a handful of signals which gives them an incomplete idea of conditions in host cells. The circuits also also built using several moving parts like different molecules of DNAs, RNAs and …

Continue reading

2017-08-29 Michael Zand NEWS

TCR2 Therapeutics to Present Solid Tumor Data at CAR-TCR Summit and CRI-CIMT-EATI-AACR International Cancer … – Markets Insider


HealthNewsReview.org

FDA announces action against two stem cell clinics: Is that a ‘crackdown’?
HealthNewsReview.org
Numerous news outlets covered the FDA’s announcements yesterday (see here and here) of enforcement action against two stem cell clinics that were alleged to offer unapproved and unsafe treatments. Many reports framed the announcement as a …
FDA Targets Unproven, Risky Treatment in Stem Cell Clinics …Newsmax
FDA cracks down on stem cell clinics | WPMT FOX43FOX43.com
FDA warns US Stem Cell Clinic in Sunrise, Florida, of significant deviationsFlorida Trend
Deccan Chronicle –Pain News Network
all 24 news articles »
Continue reading

2017-08-29 Michael Zand NEWS

SGI-DNA Sees Deal with Belgium’s VIB as Springboard to Building European Synthetic Genomics Business – GenomeWeb

TCR2 Therapeutics to Present Solid Tumor Data at CAR-TCR Summit and CRI-CIMT-EATI-AACR International Cancer …
Markets Insider
The oral presentations will discuss rationales and mechanisms for its MHC-independent TRuC™-T cells and provide additional preclinical data for TC-210, the company’s lead program targeting mesothelin-positive solid tumors including ovarian, pancreatic …

and more »

Continue reading

2017-08-29 Michael Zand NEWS

SGI-DNA Sees Deal With Belgium’s VIB as Springboard to Building European Synthetic Genomics Business – GenomeWeb

SGI-DNA Sees Deal with Belgium’s VIB as Springboard to Building European Synthetic Genomics Business
GenomeWeb
“Europe is a very large market for synthetic biology and we see particular promise in Belgium, Germany, France, Switzerland, and the UK,” Wood said. “From our perspective, research is advancing in these areas as the governments invest in research into …

Continue reading

2017-08-29 Michael Zand NEWS

Boosting immune cell memory to improve vaccines and cancer … – Science Daily

SGI-DNA Sees Deal With Belgium’s VIB as Springboard to Building European Synthetic Genomics Business
GenomeWeb
“Europe is a very large market for synthetic biology and we see particular promise in Belgium, Germany, France, Switzerland, and the UK,” Wood said. “From our perspective, research is advancing in these areas as the governments invest in research into …

Continue reading

2017-08-29 Michael Zand NEWS

Being for the $11.9bn benefit of investors of Kite: Gilead jumps into CAR T – BioPharma-Reporter.com


Science Daily

Boosting immune cell memory to improve vaccines and cancer …
Science Daily
Drugs that activate the cells’ proteasome, or recycling center, tip the balance in favor of memory CD8+ T cells, studies on mice show. This approach could be …

and more »

Continue reading

2017-08-29 Michael Zand NEWS
  • 1
  • …
  • 1,291
  • 1,292
  • 1,293
  • 1,294
  • 1,295
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

BioPharma-Reporter.com

Being for the $11.9bn benefit of investors of Kite: Gilead jumps into CAR T
BioPharma-Reporter.com
Gilead will also add a chimeric antigen receptor (CAR) T-cell manufacturing facility in El Segunda, California which opened in June last year and has the capacity to produce volumes of the autologous therapy for up to 4,000-5,000 patients per year.
Gilead agrees to buy Kite Pharma, leaping into CAR–T cancer therapySTAT
Gilead’s Plan? Cash In on CAR–TMotley Fool
Gilead just handed a revolutionary kind of cancer treatment a $12 billion endorsementBusiness Insider
Barron’s –Xconomy –Zacks Investment Research
all 333 news articles »